These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2696104)

  • 1. [Duplex ultrasound measurement of hemodynamic parameters at rest and following arterial stenosis: effect of intra-arterial infusion therapy with prostaglandin E1].
    Ranke C; Creutzig A; Alexander K
    Vasa Suppl; 1989; 27():353-5. PubMed ID: 2696104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 3. [The temporal course of hemodynamic changes following intermittent intra-arterial infusion therapy: follow-up based on duplex sonographic parameters].
    Ranke C; Creutzig A; Alexander K
    Vasa Suppl; 1991; 32():383-5. PubMed ID: 1771540
    [No Abstract]   [Full Text] [Related]  

  • 4. [Duplex ultrasound measurement of morphologic parameters before and following repeated puncture of the femoral artery for intermittent infusion therapy].
    Ranke C; Creutzig A; Alexander K
    Vasa; 1990; 19(3):203-6. PubMed ID: 2238813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic effects of intermittent intra-arterial infusion treatment with prostaglandin E1 in peripheral arterial occlusive disease].
    Ranke C; Creutzig A; Alexander K
    Med Klin (Munich); 1991 Jul; 86(7):349-52, 382. PubMed ID: 1921896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostaglandin E1 in intermittent claudication].
    Scheffler P; de la Hamette D; Rogatti W
    Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H; Brodel C; Meuche C; Hellmann G; Ranft J
    Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
    Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
    Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of patients with occlusive arterial diseases of the legs with prostaglandin E1].
    Dibirov MD
    Vestn Khir Im I I Grek; 1988 Jun; 140(6):137-8. PubMed ID: 3222855
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
    Heidrich H
    Vasa Suppl; 1991; 33():346-7. PubMed ID: 1788752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective thrombolysis with recombinant tissue type plasminogen activator in combination with prostaglandin E1].
    Bertuch H; Pilger E; Stark G; Lammer J
    Vasa Suppl; 1989; 27():240. PubMed ID: 2516366
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P; Birkel L; Grub KR; de la Hamette D
    Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of prostaglandin E1 on function and deformability of neutrophilic granulocytes in patients with stage IV peripheral arterial occlusive disease].
    Neumann FJ; Diehm C; Müller-Bühl U; Weiss T; Zimmermann R; Tillmanns H; Kübler W
    Vasa Suppl; 1989; 27():40-1. PubMed ID: 2623539
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
    Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
    Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind study of the effect of various intra-arterial/intravenous prostaglandin E1 doses on hemodynamics and prostaglandin E1 metabolites].
    Rudofsky G; Peskar BA
    Vasa Suppl; 1991; 33():345. PubMed ID: 1788751
    [No Abstract]   [Full Text] [Related]  

  • 18. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
    Hepp W; von Bary S; Corovic D; Diehm C; Mühe E; Rudofsky G; Scheffler P; Trübestein G; Vogelpohl M
    Vasa Suppl; 1991; 33():348-9. PubMed ID: 1788753
    [No Abstract]   [Full Text] [Related]  

  • 19. A new surgical approach to vasodilating therapy in peripheral occlusive vascular disease.
    Horch R; Krönung G
    Nihon Geka Hokan; 1988 Nov; 57(6):487-92. PubMed ID: 3268061
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intra-arterial infusion of PGE1 alpha cyclodextrin].
    Laurora G; Cesarone MR; Belcaro G; Incandela L; De Sanctis MT; Fascetti E; D'Archivio C
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):17-20. PubMed ID: 10658440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.